This segment focuses on the development and commercialization of Bonegrafix products, bioactive substances designed to promote bone regeneration. Research and development activities include the study of natural bone structures and processes to create materials that mimic these properties. Technologies used include biomimicry, materials science, and tissue engineering. The therapeutic area is bone replacement and defect filling, addressing conditions such as fractures, bone loss due to disease, and surgical interventions. Patient impact includes improved healing times, reduced need for secondary surgeries, and enhanced quality of life. Market positioning is in the medical device sector, competing with established bone graft manufacturers. Future opportunities include expanding the product line to address a wider range of bone defects and exploring new biomimetic materials. Regulatory aspects involve FDA approval and compliance with medical device regulations. Partnerships may include collaborations with orthopedic surgeons and research institutions.

This segment focuses on the development and marketing of ocean water-based skincare products. Research and development activities involve studying the benefits of marine-derived ingredients and formulating products to supplement skin health. Technologies used include cosmetic chemistry, nanotechnology (for nutrient delivery), and sustainable sourcing of marine resources. The therapeutic area is dermatology, addressing skin health and wellness. Patient impact includes improved skin hydration, reduced signs of aging, and enhanced skin protection. Market positioning is in the skincare market, competing with established skincare brands. Future opportunities include expanding the product line with new formulations and targeting specific skin conditions. Regulatory aspects involve compliance with FDA regulations for cosmetic products. Partnerships may include collaborations with dermatologists and skincare retailers.

This segment focuses on the research and development of Medusa technology, an electrochemical process for water treatment and hydrogen production. Research and development activities include optimizing the electrochemical process for ballast water treatment, remote potable water treatment, and hydrogen production for portable renewable energy platforms. Technologies used include electrochemistry, materials science, and water purification techniques. The therapeutic areas include environmental technology and renewable energy. Patient impact includes access to clean water and sustainable energy solutions. Market positioning is in the environmental technology and renewable energy sectors, competing with water treatment and hydrogen production companies. Future opportunities include expanding the applications of Medusa technology and commercializing the technology for various markets. Regulatory aspects involve compliance with environmental regulations and water treatment standards. Partnerships may include collaborations with environmental agencies, water treatment companies, and renewable energy providers.